Learn more

AGENEBIO INC

Overview
  • Total Patents
    86
  • GoodIP Patent Rank
    21,291
  • Filing trend
    ⇩ 63.0%
About

AGENEBIO INC has a total of 86 patent applications. It decreased the IP activity by 63.0%. Its first patent ever was published in 2011. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ADERIS PHARMACEUTICALS INC, KHONDRION IP B V and AFRAXIS HOLDINGS INC.

Patent filings per year

Chart showing AGENEBIO INCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Organic fine chemistry

Top inventors

# Name Total Patents
#1 Huang Jianxing 29
#2 Mekonnen Belew 28
#3 Butera John A 24
#4 Lowe John A Iii 12
#5 Gallagher Michela 12
#6 Melsopp Elsie 11
#7 Rosenzweig-Lipson Sharon 11
#8 James Jack Lawrence 11
#9 Smith Gardiner 9
#10 Belew Mekonnen 7

Latest patents

Publication Filing date Title
CA3104478A1 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112019012821A2 benzodiazepine derivatives, compositions and methods for the treatment of cognitive impairment
US2018170941A1 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AU2016279052A1 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX2017014774A Extended release pharmaceutical compositions of levetiracetam.
EP3297611A1 Extended release pharmaceutical compositions of levetiracetam
MX2016007808A Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment.
AU2014228512A1 Methods and compositions for improving cognitive function
WO2014078377A1 Methods and compositions for treating schizophrenia
CN103313712A Pyridazine derivatives, compositions and methods for treating cognitive impairment
EP2640396A1 Benzodiazepine derivatives, compositions and methods for treating cognitive impairment